期刊文献+

他汀类药物的临床药理与应用 被引量:13

Statins, a review of its pharmacokinetic properties and clinical practice
原文传递
导出
摘要 他汀类药物(Statins),即3-羟-3甲-戊二酰-辅酶A(HMG-CoA)还原酶抑制剂(HMG-CoA reduc—tase inhibitors),是一种新型降血脂药物,通过竞争性抑制HMG-CoA还原酶,阻断甲羟戊酸代谢的中间产物及最终产物——胆固醇的合成,降低血浆总胆固醇和LDL胆固醇,并影响机体的免疫及炎症反应、血管内皮功能、血栓形成等病理生理过程。他汀类药物有降脂和非降脂两种效应,对于延缓动脉粥样硬化进展及恶化、减少急性冠脉事件和心血管病死率,发挥着重要的作用。此类药物大多在肠道吸收,肝脏代谢,少数可直接经肾脏排泄。临床试验表明,他汀类药物安全、有效,毒副作用少。随着他汀类药物在心血管病一、二级预防中的广泛应用,有必要系统地了解本类药物的临床药理作用和常见毒副作用,为此本文特作介绍。
机构地区 解放军总医院
出处 《药物不良反应杂志》 2001年第3期145-150,共6页 Adverse Drug Reactions Journal
  • 相关文献

参考文献29

  • 1Endo A, Kurado M, Tanazawa K. Citrinin, an inhibitor of cholesterol synthesis. FEBS Lett , 1976,29: 841.
  • 2Steiner S, Gatlin CL, Lennon J J, et al. Cholesterol biosynthesis regulation and protein changes in rat liver following treatment with fluvastatin.Toxicol Lett ,2001,120(1 - 3) :369.
  • 3Pedersen TR, Wilhelmsen L, Faergeman O, et al.Follow- up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering. Am J Cardiol, 2000,86(3):257.
  • 4Hilleman DE, Wurdeman RL, Lenz TL. Therapeutic change of HMG - CoA reductase inhibitors in patients with coronary artery disease. Pharmacotherapy ,2001,21( 4 ) :410.
  • 5Hussein O, Schlezinger S, Rosenblat M, et al.Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy of the drug and its binding to the LDL.Atherosclerosis , 1997,128:11.
  • 6Girona J, Ville AE, Sola R, et al. Simvastatin de creases aldehyde production derived from lipoprotein oxidation. Am J Cardiol, 1999, 83: 846.
  • 7Williams JK, Sukhova G, Herrington DM, et al.Pravastains has cholesterol lowering independent effect on the artery wall of atheroslerotic monkeys. J Am Coll Cadiol, 1998,31:684.
  • 8Sakai M, Kobori S, Matsumura J, et al. HMGCOA reducted inhibitors surpress macrophage growth induced by oxidized low density lipoprotein.Atherosclerosis, 1997, 133:51.
  • 9Katznelson S. The inhibitory of effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro. J Heart Lung Transplant, 1998,17(40) ;335.
  • 10Pahen K, Shelkh FG, Nainboodir AM, et al. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, macrophages. J Clin Invest,1997,100:2671.

共引文献1

同被引文献69

引证文献13

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部